Enzymes, proteins that act as catalysts that increase the rate of virtually all the chemical reactions within cells, are important for treating cancer because they support the immune defense system and help eliminate cancer cells. Some enzymes can be used to break down the protective coating of cancer cells, making them more vulnerable to chemotherapy and radiation treatments.
Clinical study of an additive therapy with an oral enzyme (OE) preparation given for more than 6 months in addition to standard combination chemotherapy in patients with multiple myeloma, an incurable cancer of the blood:
The above results were achieved with relatively low-dose enzyme supplements.
Significantly higher overall response rates and longer duration of remissions were observed in the OE-group. Primary responders showed a longer mean survival time than non-responders. Additive therapy with OE given for more than 6 months decreased the hazard of death for patients at all stages of disease by approximately 60%. Observation time was not long enough to estimate the median survival for patients at stages I and II; for stage III patients it was 47 months in the control group versus 83 months for the patients treated with OE which means a 3-year gain of survival time.
The above results were achieved with relatively low-dose enzyme supplements.
Superoxide dismutase (SOD) is an enzyme that catalyzes the breakdown of superoxide radicals into oxygen and hydrogen peroxide. This enzyme can be used to increase the availability of oxygen to cancer cells, which can inhibit their growth.
.jpeg)
No comments:
Post a Comment